Difficult to Healing of Skin Ulcers Clinical Trial
— UC-MSCsOfficial title:
Umbilical Cord Mesenchymal Stem Cells Between Gel Treatment Difficult Skin Ulcer Healing Efficacy and Safety of Random, Open, Before-and-after Study
| Verified date | February 2016 |
| Source | Chinese PLA General Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | China: Ethics Committee |
| Study type | Interventional |
This study for a six-month trials, Randomized, open, and parallel comparison before and after its own, Stage test includes screening stage, treatment period and follow-up period. In accordance with chronic wound criteria for the patient, By producing the principle of random number, Were randomly divided into UC-MSCs Gel group or Gel group, The researchers according to the situation of wound healing time and decided to use the secondary treatment, To observe the clinical efficacy and safety.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 2015 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 17 Years to 78 Years |
| Eligibility |
Inclusion Criteria: - Older than 17 year old male or female (pregnancy); - Has the ability to care for, has the ability to self signed informed consent, 7 to 17 years of age must be signed by the guardian informed consent; - The process of psychological stability, can finish the tes Exclusion Criteria: - Allergic constitution, or known allergic to pork or beef source products, gao min physique person; - The wound is more than 10 cm by 10 cm; - People with mental illness, drug abusers and or other items; - 1 month used or are using the sugar metabolism of drugs, such as corticosteroids, thiazide diuretics, tricyclic antidepressants, etc; - 3 month participated in other similar test; - Serious infectious disease not controller; - With surgery, such as severe trauma stress situation; - Always had a history of tumor; - Clinical researchers or for other reasons can't cooperate with the doctors, and other information is not suitable for clinical study of patients. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| China | Chinese PLA General Hospital | Beijing |
| Lead Sponsor | Collaborator |
|---|---|
| Chinese PLA General Hospital |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Frequency of Adverse Events | Frequency and severity of Adverse Events | 6 months | Yes |
| Secondary | Relative Wound Area Regression of 40% or More at 6 Week | 6 week | Yes |